CentriFLEX Bioreactor System
Cell Therapy Manufacturing (Primary focus: CAR-T expansion)
Pre-clinicalActive
Key Facts
Indication
Cell Therapy Manufacturing (Primary focus: CAR-T expansion)
Phase
Pre-clinical
Status
Active
Company
About Ananta Technologies
Ananta Technologies is addressing a critical bottleneck in the cell therapy industry with its CentriFLEX™ bioreactor, a centrifugal fluidized expansion perfusion system designed for high-density cell culture. The platform eliminates the need for fouling-prone membrane filters and reduces reliance on expensive GMP cleanroom infrastructure, potentially cutting manufacturing time by 30% and achieving cell densities above 100 million cells/mL. The company, spun out of academic research, has garnered significant non-dilutive grant funding and accelerator support, positioning it to tackle the scalability challenges limiting the widespread adoption of life-saving CAR-T immunotherapies.
View full company profile